Inclusion Criteria:  ovarian cancer patients treated with olaparib above than 4 days patient who gave permission to take part in the trial age >18 years no history of allergy to olaparib  Exclusion Criteria:  allergy to olaparib, age under 18 years, status of the patient which do not allowed the patient to continue the study.